Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of Pregnancy?

Hepatology

Volumn 43, Issue 4, 2006, Pages 715-722

  Reyes, Humberto ^a,b   Zapata, Rodrigo ^a   Hernández, Ismael ^b   Gotteland, Martín ^a   Sandoval, Lorena ^a   Jirón, María Isabel ^a   Palma, Joaquín ^a   Almuna, Ramón ^a   Silva, Juan Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; ENDOTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTULOSE; LIPOPOLYSACCHARIDE; MANNITOL; SEX HORMONE; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE ABSORPTION; INTRAHEPATIC CHOLESTASIS; LIVER CIRCULATION; MEMBRANE PERMEABILITY; PATHOGENESIS; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

ADULT; ANTIBODIES; CASE-CONTROL STUDIES; CHOLESTASIS, INTRAHEPATIC; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; INTESTINAL MUCOSA; LACTULOSE; LIPOPOLYSACCHARIDES; MANNITOL; MONOCYTES; PERMEABILITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 33646009660     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21099     Document Type: Article

References (49)

1. Lammert F, Marschall H-U, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33:1012-1021.
2. Riely CA, Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 2004;8:167-176.
3. Reyes H, Sjövall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000;32:94-106.
4. Reyes H, Báez ME, González MC, Hernández I, Palma J, Ribalta J, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000;32:542-549.
5. Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;i:179-182.
6. Ukabam SO, Cooper BT. Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease. Dig Dis Sci 1984;29:809-816.
7. Bjarnason I, Peters TJ. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989;30:22-28.
8. Deitz EA. Intestinal permeability is increased in burn patients shortly after injury. Surgery 1990;102:411-412.
9. Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33:320-323.
10. Harris CE, Griffiths RD, Freestone N, Billingston D, Athrton ST, MacMillan RR. Intestinal permeability in the critically ill. Intensive Care Med 1992;18:38-41.
11. Van Elburg RM, Uil JJ, Mulder CJ, Heyman HS. Intestinal permeability in patients with celiac disease and relatives of patients with celiac disease. Gut 1993;34:354-357.
12. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993;104:1627-1632.
13. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581.
14. Welsh FKS, Farmery SM, MacLennan K, Sheridan MB, Barclay GR, Guillou PJ, et al. Gut barrier function in malnourished patients. Gut 1998;42:396-401.
15. Hollander D. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1999;1:410-416.
16. Kesharvazian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999;94:200-207.
17. Penalva JC, Martínez J, Laveda R, Esteban A, Muñoz C, Sáez J, et al. A study of intestinal permeability in relation to the inflammatory response and plasma Endocab IgM levels in patients with acute pancreatitis. J Clin Gastroenterol 2004;38:512-517.
18. Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. HEPATOLOGY 1981;1:458-465.
19. Nolan JP. Intestinal endotoxins as mediators of hepatic injury - an idea whose time has come again. HEPATOLOGY 1989;10:887-891.
20. Bird GLA, Sheron N, Goka AKL, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-920.
21. Gershwin ME, Ansari AA, MacKay IR, Nakahuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000;174:210-225.
22. Neuman M, Angulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, et al. Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol 2002;17:196-202.
23. Neuman MG. Cytokines - central factors in alcoholic liver disease. Alcohol Res Health 2003;27:307-316.
24. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol (Gastrointest Liver Physiol) 2004;287:G497-G502.
25. Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease: role of intestinal permeability and endotoxemia in alcoholic liver disease I. Am J Physiol (Gastroint Liver Physiol) 2004;286:G881-G884.
26. Zapata R, Sandoval L, Palma J, Hernández I, Ribalta J, Reyes H, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a 12-year experience. Liver Int 2005;25:548-554.
27. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-1626.
28. Gotteland M, Cruchet S, Frau V, Wegner ME, López R, Herrera T, et al. Effect of acute smoking, alone or with alcohol, on gastric permeability to sucrose on healthy volunteers. Dig Liver Dis 2002;34:702-706.
29. Olguín F, Araya M, Hirsch S, Brunser O, Ayala V, Rivera R, et al. Prebiotic ingestion does not improve gastrointestinal barrier function in burn patients. Burns 2005;31:482-488.
30. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994;343:998-1000.
31. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997;112:1129-1136.
32. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, Novacek G, et al. Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 1997;92:1891-1896.
33. Gotteland M, Araya M, Pizarro F, Olivares M. Effect of acute copper exposure on gastrointestinal permeability in healthy volunteers. Dig Dis Sci 2001;46:1909-1914.
34. Barclay GR. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog Clin Biol Res 1995;392:263-272.
35. Murata H, Shimizu Y, Okada K, Higuchi K, Watanabe A. Detection and analysis of intracytoplasmic cytokines in peripheral blood mononuclear cells in patients with drug-induced liver injury. J Hepatol 2003;38:573-582.
36. Rabassa AA, Goodgame R, Sutton FM, Ou CN, Rognerud C, Graham DY. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996;39:159-163.
37. Puspok A, Oberhuber G, Wyatt J, Maier-Dobersberger T, Hammer J, Pfeffel F, et al. Gastroduodenal permeability in Crohn's disease. Eur J Clin Invest 1998;28:67-71.
38. Kawabata H, Meddings JB, Uchida Y, Matsuda K, Sasahara K, Nishioka M. Sucrose permeability as a means of detecting diseases of the upper digestive tract. J Gastroenterol Hepatol 1998;13:1002-1006.
39. Di Leo V, Venturi C, Baragiotta A, Martines D, Floreani A. Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2003;15:967-973.
40. Koc B, Aymelek S, Sonmez A, Yilmaz MI, Kocar H. Increased sucrose permeability in Behcet's disease. Rheumatol Int 2004;24:347-350.
41. Johnston SD, Smye M, Watson RP. Intestinal permeability tests in coeliac disease. Clin Lab 2001;47:143-150.
42. Isolauri E, Juntunen M, Wiren S, Vuorinen P, Koivula T. Intestinal permeability changes in acute gastroenteritis: effects of clinical factors and nutritional management. J Pediatr Gastroenterol Nutr 1989;8:466-473.
43. Baron TH, Ramírez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993;118:366-375.
44. Soza A, Riquelme A, González R, Alvarez M, Pérez-Ayuso RM, Glasinovic JC, et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005;50:1136-1140.
45. Ikejima K, Enomoto N, Iimuro Y, Ikejima A, Fang D, Xu J, et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol (Gastrointest Liver Physiol) 1998;274:G669-G676.
46. Nanji AA, Jokelainen K, Fotouhinia M, Rahemtulla A, Thomas P, Tipoe GL, et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol (Gastrointest Liver Physiol) 2001;281:G1348-G1356.
47. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-624.
48. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary artery disease. Heart 1997;78:273-277.
49. Loos BG, Craandijk J, Hoek FJ, Wertheim-Van Dillen PME, Van Der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-1534.